Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
GSP Neonatal Thyroxine (T4) kit
Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage.
Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
Product information
Overview
However, increased thyroid stimulating hormone (hTSH) and decreased thyroxine are clear signs of CH, which have led to the establishment of large scale screening programs.
GSP Neonatal Thyroxine (T4) assay
The Revvity GSP Neonatal Thyroxine (T4) assay is used with dried blood spot specimens as an aid in screening newborns for congenital hypothyroidism.
- The incubation time is only 2 h
- Sensitive, robust DELFIA chemistry for confidence in results
- Not affected by EDTA, citrate or heparin in samples
- All reagents are ready to use
- The kit contains reagents and plates for 1152 tests (12 plates)
Specifications
| Application |
Newborn Screening
|
|---|---|
| Assay Technology |
DELFIA
|
| Brand |
GSP®
|
| Detection Method |
DELFIA
|
| Disorders |
Congenital Hypothyroidism
|
| Product Compatibility |
GSP
|
| Sample Type |
Dried blood spots
|
Resources
SDS, COAs, Manuals and more
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
-
LanguageEnglishCountryAustralia
-
LanguageGermanCountryAustria
-
LanguageSpanishCountryBrazil
-
LanguageEnglishCountryCanada
-
LanguageChineseCountryChina
-
LanguageDanishCountryDenmark
-
LanguageEnglishCountryEU
-
LanguageFinnishCountryFinland
-
LanguageGermanCountryGermany
-
LanguageItalianCountryItaly
Related products
of 1
How can we help you?
We are here to answer your questions.
